 Brian Flynn
Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urethral Stricture | 6 | 2024 | 13 | 2.370 |
Why?
| | Urethra | 8 | 2024 | 52 | 1.930 |
Why?
| | Pelvic Organ Prolapse | 2 | 2022 | 45 | 1.200 |
Why?
| | Mouth Mucosa | 5 | 2024 | 88 | 1.190 |
Why?
| | Urinary Incontinence | 5 | 2024 | 62 | 1.070 |
Why?
| | Laparoscopy | 3 | 2022 | 449 | 1.070 |
Why?
| | Urinary Bladder | 4 | 2014 | 175 | 0.930 |
Why?
| | Urinary Bladder Neck Obstruction | 3 | 2019 | 21 | 0.890 |
Why?
| | Ileum | 2 | 2021 | 115 | 0.800 |
Why?
| | Prostatectomy | 3 | 2024 | 106 | 0.800 |
Why?
| | Ureter | 1 | 2021 | 35 | 0.720 |
Why?
| | Ureteral Obstruction | 1 | 2021 | 62 | 0.690 |
Why?
| | Vagina | 3 | 2022 | 174 | 0.630 |
Why?
| | Surgical Mesh | 3 | 2022 | 46 | 0.620 |
Why?
| | Robotic Surgical Procedures | 1 | 2019 | 114 | 0.550 |
Why?
| | Urologic Surgical Procedures | 6 | 2021 | 107 | 0.520 |
Why?
| | Urologic Surgical Procedures, Male | 5 | 2024 | 29 | 0.480 |
Why?
| | Cystotomy | 1 | 2014 | 4 | 0.470 |
Why?
| | Urinary Retention | 2 | 2013 | 20 | 0.470 |
Why?
| | Urinary Catheters | 1 | 2014 | 8 | 0.470 |
Why?
| | Urinary Catheterization | 1 | 2014 | 25 | 0.460 |
Why?
| | Urinary Reservoirs, Continent | 1 | 2014 | 4 | 0.450 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2014 | 35 | 0.430 |
Why?
| | Vesicovaginal Fistula | 1 | 2013 | 3 | 0.430 |
Why?
| | Suburethral Slings | 1 | 2013 | 5 | 0.430 |
Why?
| | Cystostomy | 1 | 2013 | 9 | 0.420 |
Why?
| | Cystoscopy | 1 | 2013 | 18 | 0.420 |
Why?
| | Constriction, Pathologic | 3 | 2024 | 226 | 0.420 |
Why?
| | Catheters | 1 | 2013 | 66 | 0.410 |
Why?
| | Urinary Incontinence, Stress | 4 | 2013 | 14 | 0.400 |
Why?
| | Retrospective Studies | 14 | 2024 | 14455 | 0.390 |
Why?
| | Gynecologic Surgical Procedures | 2 | 2022 | 56 | 0.390 |
Why?
| | Device Removal | 1 | 2013 | 136 | 0.390 |
Why?
| | Abdominal Injuries | 1 | 2013 | 118 | 0.380 |
Why?
| | Surgical Flaps | 1 | 2013 | 135 | 0.380 |
Why?
| | Follow-Up Studies | 7 | 2021 | 4886 | 0.340 |
Why?
| | Postoperative Complications | 4 | 2022 | 2473 | 0.340 |
Why?
| | Recurrence | 5 | 2020 | 1005 | 0.320 |
Why?
| | Urinary Sphincter, Artificial | 1 | 2009 | 3 | 0.320 |
Why?
| | Aged | 14 | 2021 | 22032 | 0.320 |
Why?
| | Anastomosis, Surgical | 2 | 2014 | 149 | 0.310 |
Why?
| | Treatment Outcome | 6 | 2024 | 10199 | 0.290 |
Why?
| | Time Factors | 6 | 2021 | 6543 | 0.280 |
Why?
| | Fascia Lata | 3 | 2003 | 5 | 0.260 |
Why?
| | Uterine Prolapse | 2 | 2003 | 14 | 0.250 |
Why?
| | Reoperation | 3 | 2016 | 541 | 0.240 |
Why?
| | Middle Aged | 14 | 2021 | 31087 | 0.240 |
Why?
| | Humans | 25 | 2024 | 129248 | 0.220 |
Why?
| | Primary Health Care | 1 | 2014 | 1678 | 0.220 |
Why?
| | Operative Time | 2 | 2014 | 124 | 0.210 |
Why?
| | Prosthesis Failure | 2 | 2014 | 114 | 0.210 |
Why?
| | Male | 15 | 2024 | 63501 | 0.200 |
Why?
| | Female | 16 | 2023 | 68543 | 0.200 |
Why?
| | Cyclins | 2 | 2002 | 89 | 0.200 |
Why?
| | Pol1 Transcription Initiation Complex Proteins | 1 | 2002 | 5 | 0.200 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2002 | 53 | 0.200 |
Why?
| | Urinary Tract Infections | 2 | 2014 | 151 | 0.190 |
Why?
| | Spermatic Cord Torsion | 1 | 2002 | 3 | 0.190 |
Why?
| | Fragile X Syndrome | 1 | 2002 | 79 | 0.180 |
Why?
| | Pelvic Bones | 1 | 2003 | 156 | 0.170 |
Why?
| | Exophiala | 1 | 1999 | 1 | 0.160 |
Why?
| | Epididymis | 1 | 1999 | 12 | 0.160 |
Why?
| | Radiation Injuries | 1 | 2020 | 135 | 0.160 |
Why?
| | Adult | 9 | 2021 | 35495 | 0.150 |
Why?
| | Mycoses | 1 | 1999 | 71 | 0.150 |
Why?
| | Fractures, Bone | 1 | 2003 | 392 | 0.150 |
Why?
| | Aged, 80 and over | 4 | 2014 | 7055 | 0.130 |
Why?
| | Urination | 2 | 2014 | 44 | 0.120 |
Why?
| | Catheter Obstruction | 1 | 2014 | 4 | 0.120 |
Why?
| | Catheters, Indwelling | 1 | 2014 | 80 | 0.110 |
Why?
| | Transcription Factors | 1 | 2002 | 1647 | 0.110 |
Why?
| | Frail Elderly | 1 | 2014 | 121 | 0.110 |
Why?
| | Fascia | 1 | 2013 | 17 | 0.110 |
Why?
| | Pelvic Pain | 1 | 2013 | 32 | 0.100 |
Why?
| | Risk Reduction Behavior | 1 | 2014 | 209 | 0.100 |
Why?
| | Blood Loss, Surgical | 1 | 2013 | 93 | 0.100 |
Why?
| | Hysterectomy | 1 | 2013 | 118 | 0.100 |
Why?
| | Ligaments | 2 | 2003 | 54 | 0.100 |
Why?
| | Urodynamics | 2 | 2003 | 35 | 0.100 |
Why?
| | Colon | 1 | 2014 | 252 | 0.090 |
Why?
| | Surgical Wound Infection | 1 | 2014 | 283 | 0.090 |
Why?
| | Equipment Design | 1 | 2013 | 513 | 0.090 |
Why?
| | Comorbidity | 1 | 2014 | 1544 | 0.080 |
Why?
| | Adolescent | 3 | 2021 | 20303 | 0.080 |
Why?
| | Prevalence | 1 | 2014 | 2554 | 0.070 |
Why?
| | Length of Stay | 1 | 2013 | 1120 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2009 | 311 | 0.070 |
Why?
| | Prostatic Neoplasms | 1 | 2014 | 1016 | 0.070 |
Why?
| | Young Adult | 1 | 2021 | 12388 | 0.060 |
Why?
| | Transplantation, Homologous | 2 | 2003 | 400 | 0.060 |
Why?
| | Urography | 1 | 2003 | 16 | 0.050 |
Why?
| | Perineum | 1 | 2003 | 26 | 0.050 |
Why?
| | Rupture | 1 | 2003 | 91 | 0.050 |
Why?
| | Quality of Life | 1 | 2014 | 2685 | 0.050 |
Why?
| | Risk Factors | 1 | 2016 | 9745 | 0.050 |
Why?
| | Prospective Studies | 1 | 2014 | 7121 | 0.050 |
Why?
| | Incidence | 1 | 2009 | 2636 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2002 | 53 | 0.050 |
Why?
| | Prostheses and Implants | 1 | 2003 | 130 | 0.050 |
Why?
| | Hypertrophy | 1 | 2002 | 121 | 0.050 |
Why?
| | Organ Size | 1 | 2002 | 446 | 0.050 |
Why?
| | Testis | 1 | 2002 | 144 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2737 | 0.040 |
Why?
| | Asbestos | 1 | 1999 | 28 | 0.040 |
Why?
| | International Cooperation | 1 | 2020 | 174 | 0.040 |
Why?
| | Carcinogens | 1 | 1999 | 110 | 0.040 |
Why?
| | Cellular Senescence | 1 | 1999 | 181 | 0.030 |
Why?
| | Proteins | 1 | 2002 | 941 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2002 | 1446 | 0.030 |
Why?
| | Rats | 1 | 2002 | 5482 | 0.030 |
Why?
| | Cohort Studies | 1 | 2003 | 5408 | 0.030 |
Why?
| | Epithelial Cells | 1 | 1999 | 1063 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2002 | 3386 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 839 | 0.020 |
Why?
| | Animals | 2 | 2009 | 35307 | 0.010 |
Why?
| | Child | 1 | 2003 | 20773 | 0.010 |
Why?
| | Valsalva Maneuver | 1 | 2003 | 8 | 0.010 |
Why?
| | Urethral Obstruction | 1 | 2003 | 9 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2003 | 422 | 0.010 |
Why?
| | Asbestos, Amosite | 1 | 1999 | 1 | 0.010 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 1999 | 18 | 0.010 |
Why?
| | Pleural Neoplasms | 1 | 1999 | 24 | 0.010 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1999 | 69 | 0.010 |
Why?
| | Mesothelioma | 1 | 1999 | 38 | 0.010 |
Why?
| | Genes | 1 | 1999 | 227 | 0.010 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1999 | 117 | 0.010 |
Why?
| | Drug Resistance | 1 | 1999 | 166 | 0.010 |
Why?
| | Methylation | 1 | 1999 | 230 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2009 | 5439 | 0.010 |
Why?
| | Cell Division | 1 | 1999 | 796 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1999 | 509 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 1999 | 1691 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1999 | 2008 | 0.010 |
Why?
| | Cell Line | 1 | 1999 | 2779 | 0.010 |
Why?
| | Mice | 1 | 2009 | 16915 | 0.010 |
Why?
| | Apoptosis | 1 | 1999 | 2498 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 1999 | 2537 | 0.010 |
Why?
|
|
Flynn's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|